BWIN Director Awarded 645 Shares; Total Stake Now 10,102 – Form 4
Form 4 Snapshot (BWIN) On 07/01/2025, Baldwin Insurance Group, Inc. (ticker BWIN) filed a Form 4 disclosing that director Ellyn Shook acquired 645 shares of the company’s Class A common stock.
Rhea-AI Filing Summary
Form 4 Snapshot (BWIN)
On 07/01/2025, Baldwin Insurance Group, Inc. (ticker BWIN) filed a Form 4 disclosing that director Ellyn Shook acquired 645 shares of the company’s Class A common stock. The transaction was coded “A,” indicating a grant, award or other acquisition, and was executed at a stated price of $0.00 per share. Following the award, Shook’s direct beneficial ownership increased to 10,102 shares. No dispositions or derivative security transactions were reported.
Positive
- Director acquired 645 additional shares at a stated price of $0, increasing direct holdings to 10,102 and modestly reinforcing insider ownership alignment.
Negative
- None.
Insights
TL;DR – Small zero-cost stock award; limited market impact.
This filing reveals a routine equity grant of 645 shares to director Ellyn Shook, boosting her direct stake to 10,102 shares. Given the modest size, lack of cash consideration, and absence of accompanying derivative activity, the transaction is best viewed as standard board compensation rather than a signal of changing fundamentals. While incremental insider ownership can marginally align director and shareholder interests, the volume is unlikely to influence float or trading dynamics. Overall impact on valuation or governance posture appears neutral.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A Common Stock | 645 | $0.00 | $0.00 |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Baldwin Insurance Group (BWIN) report in its latest Form 4?
Was the transaction a purchase or an award?
Were any derivative securities involved in this Form 4 filing for BWIN?
AI-generated analysis. How Rhea-AI works. Not financial advice.